Concepedia

Author

Manu Mehta

Post Graduate Institute of Medical Education and Research

Also Known As

Aditi Mehta, Ashish Jain, M Mehta, M. Mehta, Manu Mehta

53

Publications

742

Citations

15

H-Index

35

Concepts

All Affiliations

Post Graduate Institute of Medical Education and ResearchAsian Institute of GastroenterologyAll India Institute of Medical Sciences
MM

About

Manu Mehta is an author at Post Graduate Institute of Medical Education and Research specializing in hepatology, medicine, and metabolic associated steatohepatitis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

200

2

Health Sciences

5

5

152

3

Diabetes

2

2

57

4

Epidemiology

1

1

30

5

Gastroenterology

1

1

30

Manu Mehta

×

11

Publications

442

Citations

11

H-Index

YearCitations

High potency multistrain probiotic improves liver histology in non-alcoholic fatty liver disease (NAFLD): a randomised, double-blind, proof of concept study

Ajay Duseja, Subrat Kumar Acharya, Manu Mehta,

BMJ Open Gastroenterology

2019

136

Low-Dose Sofosbuvir Is Safe and Effective in Treating Chronic Hepatitis C in Patients with Severe Renal Impairment or End-Stage Renal Disease

Sunil Taneja, Ajay Duseja, Arka De,

Digestive Diseases and Sciences

2018

48

Obstructive sleep apnea is an important predictor of hepatic fibrosis in patients with nonalcoholic fatty liver disease in a tertiary care center

Swastik Agrawal, Ajay Duseja, Ashutosh N. Aggarwal,

Hepatology International

2015

42

Vitamin D supplementation in patients with nonalcoholic fatty liver disease: A randomized controlled trial

Mallikarjun Sakpal, Sandeep Satsangi, Manu Mehta,

JGH Open

2017

41

Renal Dysfunction in Patients With Nonalcoholic Fatty Liver Disease is Related to the Presence of Diabetes Mellitus and Severity of Liver Disease

Ram Vasudevan Nampoothiri, Ajay Duseja, Manish Rathi,

Journal of Clinical and Experimental Hepatology

2017

36

Clinicopathological Profile and Outcome of a Large Cohort of Patients with Nonalcoholic Fatty Liver Disease from South Asia: Interim Results of the Indian Consortium on Nonalcoholic Fatty Liver Disease

Ajay Duseja, Shivaram Prasad Singh, Manu Mehta,

Metabolic Syndrome and Related Disorders

2022

30

Sofosbuvir and Velpatasvir combination is safe and effective in treating chronic hepatitis C in end‐stage renal disease on maintenance haemodialysis

Sunil Taneja, Ajay Duseja, Manu Mehta,

Liver International

2020

26

Can Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease Co-Exist?

Manu Mehta, Sandeep Satsangi, Ajay Duseja,

Journal of Clinical and Experimental Hepatology

2017

23

Dual treatment with sofosbuvir plus ribavirin is as effective as triple therapy with pegylated interferon plus sofosbuvir plus ribavirin in predominant genotype 3 patients with chronic hepatitis C

Sandeep Satsangi, Manu Mehta, Ajay Duseja,

Journal of Gastroenterology and Hepatology

2016

21

Lean Indian patients with non-alcoholic fatty liver disease (NAFLD) have less metabolic risk factors but similar liver disease severity as non-lean patients with NAFLD

Arka De, Manu Mehta, Priya Singh,

International Journal of Obesity

2023

21

Page 1